FDA Adverse Event Malfunction Summary report: N

CARESTART COVID-19 ANTIGEN HOME TEST

MDR report key: 20080654 · Received August 27, 2024

Report

Report Number
3003966368-2024-00004
Event Type
Malfunction
Date Received
August 27, 2024
Date of Event
July 9, 2024
Report Date
July 9, 2024
Manufacturer
ACCESS BIO INCORPORATE
Product Code
QKP
PMA / PMN Number
EUA210314
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

IN ORDER TO IDENTIFY THE TRUE ROOT CASUSE OF THIS ALLEGATION, ACCESS BIO WOULD NEED TO FURTHER COMMUNICATE WITH THE COMPLAINANT TO RULE OUT POTENTIAL ROOT CAUSES. HOWEVER, IN THE ABSENCE OF INFORMATION FROM THE CUSTOMER IT WOULD BE DIFFICULT TO RULE OUT POTENTIAL ROOT CAUSES IDENTIFIED BELOW. 1. COMPLAINANT MIGHT MISINTERPRET TEST RESULT 2. COMPLAINANT MIGHT NOT FOLLOW THE INSTRUCTIONS FOR USE (IFU) A. INADEQUATE SAMPLE COLLECTION B. INTERPRETING RESULTS BEFORE 10 MINUTES C. NOT PERFORMING TEST IMMEDIATELY AFTER OPENING THE TEST DEVICE IN THE POUCH D. POTENTIAL CONTACT WITH FOREIGN SUBSTANCES AND HOUSEHOLD CLEANING PRODUCTS DURING SAMPLE COLLECTION AND TESTING. E. OPERATING TEST OUTSDIE OF STORAGE CONDITIONS F. EXCESSIVE BUFFER APPLICATION TO SAMPLE WELL OF TEST DEVICE 3. COMPLAINANT MIGHT NOT USE THE TEST IN ACCORDANCE WITH ITS INTENDED USE A. TAKING HIGH DOSES OF BIOTIN (>10 MG PER DAY) 4. 13% OF FALSE NEGATIVE RESULTS ARE EXPECTED BASED ON PERFROMANCE CHARACTERISTICS CLAIMED FOR THIS TEST (87% PPA) 5. TESTS MIGHT BE EXPOSED TO EXTREME ENVIRONMENTAL CONITIONS DURING STORAGE ACCESS BIO WILL CONTINUE TO MONITOR FURTHER COMPLAINTS THROUGH OUR DATA TRENDING PROGRAMS AND TAKE FURTHER ACTIONS BASED ON IDENTIFIED VALID TRENDS.

Description of Event or Problem · 0

CUSTOMER TESTED NEGATIVE ON BOTH TESTS IN THE KIT BOX WHEN SHE WENT TO THE DOCTOR, SHE TESTED POSITIVE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1465348 CARESTART COVID-19 ANTIGEN HOME TEST COVID-19 ANTIGEN SELF-TEST QKP ACCESS BIO INCORPORATE N/A CP23A01

Patients

Seq Age Sex Outcome Treatment
1 0 DA Female